Navigation Links
Investor Group Commends Jim Merselis for Joining Trinity Biotech's Board of Directors & Announces Conference Call Invitation
Date:2/12/2009

KANSAS CITY, Mo., Feb. 12 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, is delighted that Jim Merselis has joined the company's board of directors. In addition to expressing support for Mr. Merselis, the group has scheduled a conference call regarding important shareholder developments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.

All those interested in participating in the call should dial 888 300 5688 and reference Conference ID 85881585.

Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreed to serve, bringing the total of independent directors to two. While Jim's agreement to join as part of our broader effort is honorable, we continue our call to action for true board oversight and management accountability. We look forward to Jim remaining as part of our new board immediately following the pending action to remove and replace the current board."

Commenting on the campaign and pending conference call, Mr. Reidy stated, "Much progress has been made that we look forward to sharing with our fellow shareholders, and we remain committed to our goals to effect the changes needed to unlock shareholder value and provide the level of transparency we have continued to advocate."

Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Champions Biotechnology, Inc.s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
2. Genaera to Present at BIO CEO & Investor Conference
3. Rigel to Present at BIO CEO & Investor Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
7. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
8. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
9. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
10. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at a ... to wait until March 2017 for an interest rate increase, according to Rajeev Dhawan ... Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
(Date:5/25/2016)... , May 25, 2016 ... H1 2016"market research report that provides an overview ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology: